BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 34328251)

  • 21. Graves' disease associated with HIV disease and late immune reconstitution inflammatory syndrome following the initiation of antiretroviral therapy.
    Ludgate S; Connolly SP; Fennell D; Muhamad MF; Welaratne I; Cotter A; McQuaid SE
    Endocrinol Diabetes Metab Case Rep; 2021 Oct; 2021():. PubMed ID: 34612207
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Age moderates the associations between TRAbs, free T3 and outcomes of Graves' disease patients with radioactive iodine treatment.
    Lu L; Gao C; Zhang N
    Clin Endocrinol (Oxf); 2021 Feb; 94(2):303-309. PubMed ID: 32734611
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Radioiodine treatment of hyperthyroidism: prognostic factors affecting outcome.
    Erem C; Kandemir N; Hacihasanoglu A; Ersöz HO; Ukinc K; Kocak M
    Endocrine; 2004 Oct; 25(1):55-60. PubMed ID: 15545707
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characteristics of paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome and its influence on tuberculosis treatment outcomes in persons living with HIV.
    Narendran G; Jyotheeswaran K; Senguttuvan T; Vinhaes CL; Santhanakrishnan RK; Manoharan T; Selvaraj A; Chandrasekaran P; Menon PA; Bhavani KP; Reddy D; Narayanan R; Subramanyam B; Sathyavelu S; Krishnaraja R; Kalirajan P; Angamuthu D; Susaimuthu SM; Ganesan RRK; Tripathy SP; Swaminathan S; Andrade BB
    Int J Infect Dis; 2020 Sep; 98():261-267. PubMed ID: 32623087
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immune reconstitution inflammatory syndrome in adult human immunodeficiency virus-infected patients in Thailand.
    Aramaki M; Silachamroon U; Desakorn V; Maek-A-nantawat W; Waiwaruwut J; Jutiwarakun K; Kim JH; Pitisuttithum P
    Southeast Asian J Trop Med Public Health; 2010 Jan; 41(1):138-45. PubMed ID: 20578492
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of high tissue-absorbed dose on anti-thyroid antibodies in radioiodine therapy of Graves' disease patients.
    Listewnik MH; Piwowarska-Bilska H; Jasiakiewicz K; Birkenfeld B
    Adv Clin Exp Med; 2021 Sep; 30(9):913-921. PubMed ID: 34418335
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sequential occurrence of Graves' disease and immune thrombocytopenic purpura as manifestations of immune reconstitution inflammatory syndrome in an HIV-infected patient.
    Okazaki M; Nakamura M; Imai A; Asagiri T; Takeuchi S
    Int J STD AIDS; 2018 Jul; 29(8):834-836. PubMed ID: 29361886
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comorbidity of Myasthenia gravis and Graves' disease as immune reconstitution-associated autoimmune disease in HIV infection: A case report and literature review.
    Lu L; Ma Y; Cong Y; Zhou B; Chen Y; Niu J; He Y; Cao W; Li T
    HIV Med; 2024 Mar; 25(3):398-403. PubMed ID: 37990629
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of lithium on efficacy of radioactive iodine therapy for Graves' disease: a cohort study on cure rate, time to cure, and frequency of increased serum thyroxine after antithyroid drug withdrawal.
    Bogazzi F; Giovannetti C; Fessehatsion R; Tanda ML; Campomori A; Compri E; Rossi G; Ceccarelli C; Vitti P; Pinchera A; Bartalena L; Martino E
    J Clin Endocrinol Metab; 2010 Jan; 95(1):201-8. PubMed ID: 19906789
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adjuvant lithium improves the efficacy of radioactive iodine treatment in Graves' and toxic nodular disease.
    Martin NM; Patel M; Nijher GM; Misra S; Murphy E; Meeran K
    Clin Endocrinol (Oxf); 2012 Oct; 77(4):621-7. PubMed ID: 22443227
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Changes in thyroid volume in response to radioactive iodine for Graves' hyperthyroidism correlated with activity of thyroid-stimulating antibody and treatment outcome.
    Murakami Y; Takamatsu J; Sakane S; Kuma K; Ohsawa N
    J Clin Endocrinol Metab; 1996 Sep; 81(9):3257-60. PubMed ID: 8784079
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term follow-up study of radioiodine treatment of hyperthyroidism.
    Metso S; Jaatinen P; Huhtala H; Luukkaala T; Oksala H; Salmi J
    Clin Endocrinol (Oxf); 2004 Nov; 61(5):641-8. PubMed ID: 15521969
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Graves' immune reconstitution inflammatory syndrome in childhood.
    Sinha A; Abinun M; Gennery AR; Barge D; Slatter M; Cheetham T
    Thyroid; 2013 Aug; 23(8):1010-4. PubMed ID: 23556479
    [TBL] [Abstract][Full Text] [Related]  

  • 34. What influences early hypothyroidism after radioiodine treatment for Graves' hyperthyroidism?
    Vijayakumar V; Ali S; Nishino T; Nusynowitz M
    Clin Nucl Med; 2006 Nov; 31(11):688-9. PubMed ID: 17053385
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment with propylthiouracil before radioactive iodine therapy is associated with a higher treatment failure rate than therapy with radioactive iodine alone in Graves' disease.
    Tuttle RM; Patience T; Budd S
    Thyroid; 1995 Aug; 5(4):243-7. PubMed ID: 7488862
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk factors for 'unmasking immune reconstitution inflammatory syndrome' presentation of tuberculosis following combination antiretroviral therapy initiation in HIV-infected patients.
    Valin N; Pacanowski J; Denoeud L; Lacombe K; Lalande V; Fonquernie L; Girard PM; Meynard JL
    AIDS; 2010 Jun; 24(10):1519-25. PubMed ID: 20549841
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Patterns of Use, Efficacy, and Safety of Treatment Options for Patients with Graves' Disease: A Nationwide Population-Based Study.
    Brito JP; Payne S; Singh Ospina N; Rodriguez-Gutierrez R; Maraka S; Sangaralingham LR; Iñiguez-Ariza NM; Montori VM; Stan MN
    Thyroid; 2020 Mar; 30(3):357-364. PubMed ID: 31973681
    [No Abstract]   [Full Text] [Related]  

  • 38. Evidence for higher success rates and successful treatment earlier in Graves' disease with higher radioactive iodine doses.
    Sztal-Mazer S; Nakatani VY; Bortolini LG; Boguszewski CL; Graf H; de Carvalho GA
    Thyroid; 2012 Oct; 22(10):991-5. PubMed ID: 22953990
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The tale of radioiodine and Graves' orbitopathy.
    Ponto KA; Zang S; Kahaly GJ
    Thyroid; 2010 Jul; 20(7):785-93. PubMed ID: 20578895
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Outcomes of Graves' Disease Patients Following Antithyroid Drugs, Radioactive Iodine, or Thyroidectomy as the First-line Treatment.
    Liu X; Wong CKH; Chan WWL; Tang EHM; Woo YC; Lam CLK; Lang BHH
    Ann Surg; 2021 Jun; 273(6):1197-1206. PubMed ID: 33914484
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.